Bim SM-2

General Information


DRACP ID  DRACP03048

Peptide Name   Bim SM-2

Sequence  IWIAQELRRIGDEF

Sequence Length  14

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Induce apoptosis Bac-2 inhibitors BH3 peptides and mimetics



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Bcl-2

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP03048

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Acetylation

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C80H124N22O22

Absent amino acids  CHKMNPSTVY

Common amino acids  I

Mass  197807

Pl  4.43

Basic residues  2

Acidic residues  3

Hydrophobic residues  7

Net charge  -1

Boman Index  -2998

Hydrophobicity  -17.14

Aliphatic Index  118.57

Half Life 
  Mammalian: 20 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  5500

Absorbance 280nm  423.08

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Discovery of novel inhibitors of anti-apoptotic Bcl-2proteins derived from Bim BH3 domain

Doi 10.1016/j.cclet.2017.03.010

Year  2017

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.